224 related articles for article (PubMed ID: 37271109)
1. Sex hormones, insomnia, and sleep quality: Subjective sleep in the first year of hormone use in transgender persons.
Morssinkhof MWL; Wiepjes CM; Bosman BW; Kinds J; Fisher AD; Greenman Y; Kreukels BPC; T'Sjoen G; van der Werf YD; Heijer MD; Broekman BFP
Sleep Med; 2023 Jul; 107():316-326. PubMed ID: 37271109
[TBL] [Abstract][Full Text] [Related]
2. Influence of sex hormone use on sleep architecture in a transgender cohort.
Morssinkhof MWL; van der Werf YD; van den Heuvel OA; van den Ende DA; van der Tuuk K; den Heijer M; Broekman BFP
Sleep; 2023 Nov; 46(11):. PubMed ID: 37715990
[TBL] [Abstract][Full Text] [Related]
3. Gender-affirming hormone therapy induces specific DNA methylation changes in blood.
Shepherd R; Bretherton I; Pang K; Mansell T; Czajko A; Kim B; Vlahos A; Zajac JD; Saffery R; Cheung A; Novakovic B
Clin Epigenetics; 2022 Feb; 14(1):24. PubMed ID: 35177097
[TBL] [Abstract][Full Text] [Related]
4. Gender affirming hormonal treatment in Danish transgender persons: A nationwide register-based study.
Glintborg D; Rubin KH; Kristensen SB; Lidegaard Ø; T'Sjoen G; Hilden M; Andersen MS
Andrology; 2022 Jul; 10(5):885-893. PubMed ID: 35366390
[TBL] [Abstract][Full Text] [Related]
5. Changes in depression symptom profile with gender-affirming hormone use in transgender persons.
Morssinkhof MWL; Wiepjes CM; van den Heuvel OA; Kreukels BPC; van der Tuuk K; T'Sjoen G; den Heijer M; Broekman BFP
J Affect Disord; 2024 Mar; 348():323-332. PubMed ID: 38154588
[TBL] [Abstract][Full Text] [Related]
6. Clinicians in the Veterans Health Administration initiate gender-affirming hormone therapy in concordance with clinical guideline recommendations.
Jasuja GK; Wolfe HL; Reisman JI; Vimalananda VG; Rao SR; Blosnich JR; Livingston NA; Shipherd JC
Front Endocrinol (Lausanne); 2024; 15():1086158. PubMed ID: 38800485
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
[TBL] [Abstract][Full Text] [Related]
8. Hormone Concentrations in Transgender Women Who Self-Prescribe Gender Affirming Hormone Therapy: A Retrospective Study.
Salakphet T; Mattawanon N; Manojai N; Muangmool T; Tangpricha V
J Sex Med; 2022 May; 19(5):864-871. PubMed ID: 35379590
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of and factors associated with the use of gender-affirming hormonal therapy outside the reference regimen among transgender people in a community-led clinic in Metro Manila, Philippines: a retrospective cross-sectional study.
Eustaquio PC; Dela Cruz JDM; Araña Y; Rosos B; Rosadiño JDT; Pagtakhan RG; Regencia ZJG; Baja ES
BMJ Open; 2023 Sep; 13(9):e072252. PubMed ID: 37669846
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Gender-Affirming Hormone Therapy on the Risk of Subclinical Atherosclerosis in the Transgender Population: A Systematic Review.
Moreira Allgayer RMC; Borba GDS; Moraes RS; Ramos RB; Spritzer PM
Endocr Pract; 2023 Jun; 29(6):498-507. PubMed ID: 36603652
[TBL] [Abstract][Full Text] [Related]
11. Chronotype changes after sex hormone use: A prospective cohort study in transgender users of gender-affirming hormones.
Morssinkhof MWL; Zwager A; van der Tuuk K; den Heijer M; van der Werf YD; Stenvers DJ; Broekman BFP
Chronobiol Int; 2024 May; 41(5):658-668. PubMed ID: 38616311
[TBL] [Abstract][Full Text] [Related]
12. Effect of gender-affirming hormone therapy on hair growth: a systematic review of the literature.
Tang GT; Zwickl S; Sinclair R; Zajac JD; Cheung AS
Clin Exp Dermatol; 2023 Sep; 48(10):1117-1127. PubMed ID: 37311161
[TBL] [Abstract][Full Text] [Related]
13. Addition of progesterone to feminizing gender-affirming hormone therapy in transgender individuals for breast development: a randomized controlled trial.
Dijkman BAM; Helder D; Boogers LS; Gieles NC; van Heesewijk JO; Slaa ST; Liberton NPTJ; Wiepjes CM; de Blok CJM; den Heijer M; Dreijerink KMA
BMC Pharmacol Toxicol; 2023 Dec; 24(1):80. PubMed ID: 38124194
[TBL] [Abstract][Full Text] [Related]
14. Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study.
Foster Skewis L; Bretherton I; Leemaqz SY; Zajac JD; Cheung AS
Front Endocrinol (Lausanne); 2021; 12():717766. PubMed ID: 34394009
[TBL] [Abstract][Full Text] [Related]
15. MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people.
Glintborg D; T'Sjoen G; Ravn P; Andersen MS
Eur J Endocrinol; 2021 Jun; 185(2):R49-R63. PubMed ID: 34081614
[TBL] [Abstract][Full Text] [Related]
16. Transgender health and the impact of aging and menopause.
Cheung AS; Nolan BJ; Zwickl S
Climacteric; 2023 Jun; 26(3):256-262. PubMed ID: 37011669
[TBL] [Abstract][Full Text] [Related]
17. Thrombosis Risk in Transgender Adolescents Receiving Gender-Affirming Hormone Therapy.
Mullins ES; Geer R; Metcalf M; Piccola J; Lane A; Conard LAE; Mullins TLK
Pediatrics; 2021 Apr; 147(4):. PubMed ID: 33753543
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular outcomes in transgender individuals in Sweden after initiation of gender-affirming hormone therapy.
Karalexi MA; Frisell T; Cnattingius S; Holmberg D; Holmberg M; Kollia N; Skalkidou A; Papadopoulos FC
Eur J Prev Cardiol; 2022 Nov; 29(15):2017-2026. PubMed ID: 35778824
[TBL] [Abstract][Full Text] [Related]
19. New Insights Into Extended Steroid Hormone Profiles in Transwomen in a Multi-Center Setting in Germany.
Schneider F; Wistuba J; Holterhus PM; Kulle A; Schlatt S; Kliesch S; Neuhaus N; Zitzmann M
J Sex Med; 2021 Oct; 18(10):1807-1817. PubMed ID: 34600646
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
